Cargando…
Editorial: Neuroprotection and disease modification in Parkinson’s disease: Volume II
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868301/ https://www.ncbi.nlm.nih.gov/pubmed/36699074 http://dx.doi.org/10.3389/fphar.2022.1121513 |
| _version_ | 1784876503745429504 |
|---|---|
| author | Otero-Losada, Matilde Gubellini, Paolo Capani, Francisco Perez-Lloret, Santiago |
| author_facet | Otero-Losada, Matilde Gubellini, Paolo Capani, Francisco Perez-Lloret, Santiago |
| author_sort | Otero-Losada, Matilde |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9868301 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98683012023-01-24 Editorial: Neuroprotection and disease modification in Parkinson’s disease: Volume II Otero-Losada, Matilde Gubellini, Paolo Capani, Francisco Perez-Lloret, Santiago Front Pharmacol Pharmacology Frontiers Media S.A. 2023-01-09 /pmc/articles/PMC9868301/ /pubmed/36699074 http://dx.doi.org/10.3389/fphar.2022.1121513 Text en Copyright © 2023 Otero-Losada, Gubellini, Capani and Perez-Lloret. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Pharmacology Otero-Losada, Matilde Gubellini, Paolo Capani, Francisco Perez-Lloret, Santiago Editorial: Neuroprotection and disease modification in Parkinson’s disease: Volume II |
| title | Editorial: Neuroprotection and disease modification in Parkinson’s disease: Volume II |
| title_full | Editorial: Neuroprotection and disease modification in Parkinson’s disease: Volume II |
| title_fullStr | Editorial: Neuroprotection and disease modification in Parkinson’s disease: Volume II |
| title_full_unstemmed | Editorial: Neuroprotection and disease modification in Parkinson’s disease: Volume II |
| title_short | Editorial: Neuroprotection and disease modification in Parkinson’s disease: Volume II |
| title_sort | editorial: neuroprotection and disease modification in parkinson’s disease: volume ii |
| topic | Pharmacology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868301/ https://www.ncbi.nlm.nih.gov/pubmed/36699074 http://dx.doi.org/10.3389/fphar.2022.1121513 |
| work_keys_str_mv | AT oterolosadamatilde editorialneuroprotectionanddiseasemodificationinparkinsonsdiseasevolumeii AT gubellinipaolo editorialneuroprotectionanddiseasemodificationinparkinsonsdiseasevolumeii AT capanifrancisco editorialneuroprotectionanddiseasemodificationinparkinsonsdiseasevolumeii AT perezlloretsantiago editorialneuroprotectionanddiseasemodificationinparkinsonsdiseasevolumeii |